Observational comparative effectiveness studies of drug therapies: High-quality answers or important clinical questions?

Archives of Internal Medicine

Volumn 172, Issue 18, 2012, Pages 1412-1414

  Floyd, James S ^a,b   Psaty, Bruce M ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE; THIAZIDE DIURETIC AGENT;

CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CONGESTIVE HEART FAILURE; DRUG INDICATION; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; NOTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; STROKE;

EID: 84867379814     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.4306     Document Type: Note

References (16)

1. Freemantle N, Cleland J, Young P, Mason J, Harrison J. β Blockade aftermyocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730-1737.
2. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784-794.
3. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
4. Psaty BM, Weiss NS, Furberg CD. Recent trials in hypertension: compelling science or commercial speech? JAMA. 2006;295(14):1704-1706.
5. Dahlöf B, Devereux RB, Kjeldsen SE, et al; LIFE Study Group. Cardiovascular morbidity andmortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003.
6. Dahlöf B, Sever PS, Poulter NR, et al; ASCOT Investigators. Prevention ofcardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906.
7. Parker ED, Margolis KL, Trower NK, et al. Comparative effectiveness of 2 β-blockers in hypertensive patients [published online August 27, 2012]. Arch Intern Med. 2012;172(18):1406-1412.
8. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-920. (Pubitemid 37323253)
9. Poirier L, Lacourcière Y. The evolving role of β-adrenergic receptor blockers in managing hypertension. Can J Cardiol. 2012;28(3):334-340.
10. Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766-779.
11. Psaty BM, Siscovick DS. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA. 2010;304(8):897-898.
12. Gottlieb SS, McCarter RJ. Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction. Am J Cardiol. 2001;87(7):823-826. (Pubitemid 32244198)
13. Hennessy S. When should we believe nonrandomized studies of comparative effectiveness? Clin Pharmacol Ther. 2011;90(6):764-766.
14. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? a meta-analysis. Lancet. 2005;366(9496):1545-1553. (Pubitemid 41540112)
15. Wiysonge CS, Bradley H, Mayosi BM, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2007;(1):CD002003.
16. Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension. 2012;59(6):1110-1117.